BackgroundCheck.run
Search For

Jane Connor, 54Williamsburg, VA

Known as:
Jan E Connor Jane Conner Jan E Conner
Related to:
Christy A Walsh 48 Avery J Nasworthy 25

Jane Connor Phones & Addresses

Williamsburg, VA   

Washington, DC   

Harker Heights, TX   

9100 Nana Russell Rd, Owings, MD 20736    254-8331122   

Fayetteville, NC   

Burke, VA   

Watertown, MA   

Get Report
Control this profile

Mentions for Jane Connor

Jane Connor resumes & CV records

Resumes

Jane Connor Photo 32

Associate Director

Location:
Washington, DC
Industry:
Pharmaceuticals
Work:
Medimmune 2008 - 2010
Principal Scientist and Associate Director Astrazeneca 2008 - 2010
Associate Director Pfizer 1992 - 2007
Principal Scientist
Jane Connor Photo 33

Jane Connor

Jane Connor Photo 34

Jane Connor

Jane Connor Photo 35

Jane Connor

Jane Connor Photo 36

Jane Connor

Jane Connor Photo 37

Jane O Connor

Jane Connor Photo 38

Jane Connor

Location:
Washington, DC
Industry:
Primary/Secondary Education
Work:
Fairfax County Public Schools
Teacher
Skills:
Leadership, Public Speaking, Literacy, Social Studies, Teaching, Guided Reading, Government, Elementary Education, Balanced Literacy, Fundraising, Lesson Planning, Smartboard, Program Management, Differentiated, Nonprofits, Tutoring, Classroom Management, Community Outreach, Policy, Secondary Education, Language Arts, Non Profits, Educational Technology, Project Management, Classroom
Jane Connor Photo 39

Jane Connor

Publications & IP owners

Us Patents

Methods Of Treatment With Angiopoietin-2 Antibodies

US Patent:
2018021, Aug 2, 2018
Filed:
Nov 22, 2017
Appl. No.:
15/820943
Inventors:
- Gaithersburg MD, US
- Helsinki, FI
Karl Lemstrom - Helsinki, FI
Ching Ching Leow - Gaithersburg MD, US
Ronald Herbst - Gaithersburg MD, US
Jane Connor - Gaithersburg MD, US
International Classification:
C07K 16/22
A61K 39/395
Abstract:
The disclosure is directed to methods and uses of antibodies or antigen-binding fragments thereof against Angiopoietin-2 (Ang-2). Specifically, the disclosure is direct to the use of anti-Ang2 antibodies or antigen-binding fragments thereof for treating ischemia. The methods disclosed are useful for reducing microvascular permeability, increasing microvascular perfusion, reducing inflammation in a tissue, and treating or ameliorating diseases associated with ischemia and/or reperfusion injury. The disclosed methods are also useful for protecting solid organ transplant tissue and treating or preventing chronic tissue transplant rejection.

Methods Of Treatment With Angiopoietin-2 Antibodies

US Patent:
2016022, Aug 4, 2016
Filed:
Jan 29, 2016
Appl. No.:
15/010253
Inventors:
- Gaithersburg MD, US
- Helsinki, FI
KARL LEMSTROM - HELSINKI, FI
CHING CHING LEOW - GAITHERSBURG MD, US
RONALD HERBST - GAITHERSBURG MD, US
JANE CONNOR - GAITHERSBURG MD, US
International Classification:
C07K 16/22
Abstract:
The disclosure is directed to methods and uses of antibodies or antigen-binding fragments thereof against Angiopoietin-2 (Ang-2). Specifically, the disclosure is direct to the use of anti-Ang2 antibodies or antigen-binding fragments thereof for treating ischemia. The methods disclosed are useful for reducing microvascular permeability, increasing microvascular perfusion, reducing inflammation in a tissue, and treating or ameliorating diseases associated with ischemia and/or reperfusion injury. The disclosed methods are also useful for protecting solid organ transplant tissue and treating or preventing chronic tissue transplant rejection.

Methods Of Treatment With Angiopoietin-2 Antibodies

US Patent:
2015004, Feb 12, 2015
Filed:
Mar 7, 2013
Appl. No.:
14/383377
Inventors:
Kari ALITALO - Helsinki, FI
Simo SYRJALA - Helsinki, FI
Karl M. LEMSTROM - Helsinki, FI
- Gaithersburg MD, US
Ronald Herbst - Gaithersburg MD, US
Jane Connor - Gaithersburg MD, US
International Classification:
A61K 39/395
US Classification:
4241581
Abstract:
The disclosure is directed to methods and uses of antibodies or antigen-binding fragments thereof against Angiopoietin-2 (Ang-2). Specifically, the disclosure is direct to the use of anti-Ang2 antibodies or antigen-binding fragments thereof for treating ischemia. The methods disclosed are useful for reducing microvascular permeability, increasing microvascular perfusion, reducing inflammation in a tissue, and treating or ameliorating diseases associated with ischemia and/or reperfusion injury. The disclosed methods are also useful for protecting solid organ transplant tissue and treating or preventing chronic tissue transplant rejection.

Isbn (Books And Publications)

Children'S Library Services Handbook

Author:
Jane Gardner Connor
ISBN #:
0897744896

Possible Relatives

David M Connor  Dean T Connor  Daisy M Connor  Dale P Connor  Damon Connor  Deborah A Connor  Debra L Connor  Jane M Johnson  Jane E Johnston  Jane I Stanford 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.